Search

everythinglearnresearchcommunity

for

Search:↓

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Diphencyprone helped most patients with alopecia areata regrow some hair.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.